Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women
Coronary artery disease is both underdiagnosed and undertreated in women, and they often receive less guideline-recommended care than men. Why do these disparities persist? And what can today’s healthcare providers do to bring about change?
FDA clears catheter-based 4D visualization platform for complex heart procedures
The new technology from LUMA Vision allows operators to deliver 2D and 4D ultrasound images in real time. The advanced catheter was built with maneuverability and increased visibility in mind.
FDA approves leadless CRT device for heart failure
The WiSE CRT system is approximately the size of a single cooked grain of rice. It works with a patient’s existing implant to provide biventricular pacing.
AI bests radiologists at computed tomography angiography reads
CTA offers enhanced visualization for radiologists to assess patients’ risk of CAD, but the manual quantification process can be time-consuming.
FDA clears AI-powered echocardiography software
HeartFocus guides users through the entire process, making it so that even novices can deliver high-quality echocardiograms every time.

Using advanced artificial intelligence (AI) platforms to assess imaging results and quantify coronary plaque buildup can help clinicians predict adverse events in patients with suspected coronary artery disease (CAD), according to late-breaking data presented at TCT 2024 in Washington, D.C.

AI-enabled plaque assessments help cardiologists ID high-risk CAD patients

AI-enabled coronary plaque assessments deliver significant value, according to late-breaking data presented at TCT. These AI platforms have gained considerable momentum in recent months, receiving expanded Medicare coverage in addition to a new Category I CPT code.

Abbott’s FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system

Abbott CGM sensors can now be worn during common imaging procedures

Sensors from the FreeStyle Libre 2 and Libre 3 continuous glucose monitoring systems can now be worn during X-rays, CT scans and MRI scans. The news represents a shift in policy from the FDA, one that came after the agency reviewed extensive testing data.

TTVR with Evoque device linked to substantial benefits after 1 year

New late-breaking data presented at TCT confirmed that the first FDA-approved TTVR system for TR is associated with a much better quality of life than medical therapy alone after one year.

Heart Rhythm Society launches new group focused on EP advocacy

The new organization, Heart Rhythm Advocates, will urge federal policymakers to pass legislation and support actions that have a positive impact on the future of electrophysiology.

New data highlight long-term benefits of HeartFlow’s AI-based CAD evaluations

HeartFlow kicked off TCT 2024 by sharing new research on the long-term impact of its FFR_CT Analysis and Plaque Analysis software.

Medicare coverage expands again for AI-enabled coronary plaque assessments

Another MAC has agreed to cover the use of these advanced technologies to evaluate patients for signs of coronary artery disease.

Medtronic's Affera mapping and ablation system with the Sphere-9 catheter

FDA approves Medtronic’s new all-in-one mapping and ablation system for AFib

Medtronic is now the first company to offer two FDA-approved PFA systems for the treatment of persistent AFib. The company’s PulseSelect PFA system gained approval in December 2023.

GE HealthCare Omni Legend PET/CT scanner production North America United States

GE HealthCare moves PET/CT scanner production to United States

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.

Cardiac Imaging

Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women

FDA clears catheter-based 4D visualization platform for complex heart procedures

FDA approves leadless CRT device for heart failure

AI bests radiologists at computed tomography angiography reads

FDA clears AI-powered echocardiography software